Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
NCT00407498
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasm
Interventions
DRUG:
P276-00
Sponsor
Piramal Enterprises Limited